Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 USD | -1.83% | -5.80% | -11.70% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 18 | Amneal Pharmaceuticals Announces Launch of Pemetrexed Injection, 100mg/10 Mg/10 Mg/50 Mg/Ll | CI |
Financials (USD)
Sales 2024 * | 2.6B | Sales 2025 * | 2.73B | Capitalization | 1.65B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 22M | EV / Sales 2024 * | 1.52 x |
Net Debt 2024 * | 2.29B | Net Debt 2025 * | 2.07B | EV / Sales 2025 * | 1.37 x |
P/E ratio 2024 * |
107
x | P/E ratio 2025 * |
59.6
x | Employees | 7,850 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 24.26% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | -1.83% | ||
1 week | -5.80% | ||
Current month | -11.55% | ||
1 month | -9.31% | ||
3 months | +0.94% | ||
6 months | +48.48% | ||
Current year | -11.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 5.36 | -1.83% | 843,286 |
24-04-17 | 5.46 | +0.18% | 1,220,455 |
24-04-16 | 5.45 | -1.62% | 1,203,914 |
24-04-15 | 5.54 | +0.36% | 1,117,966 |
24-04-12 | 5.52 | -2.99% | 2,184,811 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.70% | 1.68B | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- AMRX Stock